Rachel K. King is of GLYCOMIMETICS INC. Currently has a direct ownership of 515,194 shares of GLYC, which is worth approximately $118,494. The most recent transaction as insider was on Mar 29, 2024, when has been sold 3,334 shares (Common Stock) at a price of $3.0 per share, resulting in proceeds of $10,002. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 515K
0% 3M change
1.49% 12M change
Total Value Held $118,494

Rachel K. King Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 29 2024
BUY
Grant, award, or other acquisition
$10,002 $3.0 p/Share
3,334 Added 0.64%
515,194 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
$10,001 $2.36 p/Share
4,238 Added 0.82%
511,860 Common Stock
Sep 30 2023
BUY
Grant, award, or other acquisition
$10,000 $1.5 p/Share
6,667 Added 1.3%
507,622 Common Stock
Jan 20 2021
BUY
Grant, award, or other acquisition
-
96,250 Added 17.55%
452,314 Common Stock
Dec 28 2020
SELL
Open market or private sale
$329,128 $3.91 p/Share
84,176 Reduced 19.12%
356,064 Common Stock
Dec 28 2020
BUY
Exercise of conversion of derivative security
$146,520 $1.12 p/Share
130,821 Added 22.91%
440,240 Common Stock

Also insider at

NVAX
NOVAVAX INC Healthcare
FULC
Fulcrum Therapeutics, Inc. Healthcare
RKK

Rachel K. King

Gaithersburg, MD

Track Institutional and Insider Activities on GLYC

Follow GLYCOMIMETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLYC shares.

Notify only if

Insider Trading

Get notified when an Glycomimetics Inc insider buys or sells GLYC shares.

Notify only if

News

Receive news related to GLYCOMIMETICS INC

Track Activities on GLYC